Transcriptomic biomarker development for ulcerative colitis patients at-risk of developing colon cancer and therapeutic response to infliximab

Original language	English
Publication status	Published - 21 Feb 2019
Event	55th Irish Association for Cancer Research Conference 2019 - Europa Hotel, Belfast, United Kingdom Duration: 20 Feb 2019 → 22 Feb 2019 https://www.iacr.ie/2019-annual-conference/

Conference

Conference	55th Irish Association for Cancer Research Conference 2019
Abbreviated title	IACR 2019
Country/Territory	United Kingdom
City	Belfast
Period	20/02/2019 → 22/02/2019
Internet address	https://www.iacr.ie/2019-annual-conference/

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

• 

Student theses

• A bioinformatics approach to identifying ulcerative colitis patients at-risk of developing colorectal cancer

  Scanlon, E. (Author), Kennedy, R. (Supervisor) & Blayney, J. (Supervisor), Dec 2023

  Student thesis: Doctoral Thesis › Doctor of Philosophy

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Scanlon, E. (2019). Transcriptomic biomarker development for ulcerative colitis patients at-risk of developing colon cancer and therapeutic response to infliximab. Paper presented at 55th Irish Association for Cancer Research Conference 2019, Belfast, United Kingdom.

Scanlon, Enya. / Transcriptomic biomarker development for ulcerative colitis patients at-risk of developing colon cancer and therapeutic response to infliximab. Paper presented at 55th Irish Association for Cancer Research Conference 2019, Belfast, United Kingdom.

@conference{11019b3045b94736a90ace68242bf3ac,

title = "Transcriptomic biomarker development for ulcerative colitis patients at-risk of developing colon cancer and therapeutic response to infliximab",

author = "Enya Scanlon",

year = "2019",

month = feb,

day = "21",

language = "English",

note = "55th Irish Association for Cancer Research Conference 2019, IACR 2019 ; Conference date: 20-02-2019 Through 22-02-2019",

url = "https://www.iacr.ie/2019-annual-conference/",

}

Scanlon, E 2019, 'Transcriptomic biomarker development for ulcerative colitis patients at-risk of developing colon cancer and therapeutic response to infliximab', Paper presented at 55th Irish Association for Cancer Research Conference 2019, Belfast, United Kingdom, 20/02/2019 - 22/02/2019.

Transcriptomic biomarker development for ulcerative colitis patients at-risk of developing colon cancer and therapeutic response to infliximab. / Scanlon, Enya.
2019. Paper presented at 55th Irish Association for Cancer Research Conference 2019, Belfast, United Kingdom.

Research output: Contribution to conference › Paper › peer-review

TY - CONF

T1 - Transcriptomic biomarker development for ulcerative colitis patients at-risk of developing colon cancer and therapeutic response to infliximab

AU - Scanlon, Enya

PY - 2019/2/21

Y1 - 2019/2/21

M3 - Paper

T2 - 55th Irish Association for Cancer Research Conference 2019

Y2 - 20 February 2019 through 22 February 2019

ER -

Scanlon E. Transcriptomic biomarker development for ulcerative colitis patients at-risk of developing colon cancer and therapeutic response to infliximab. 2019. Paper presented at 55th Irish Association for Cancer Research Conference 2019, Belfast, United Kingdom.